Skip to main content
Caplight Logo









Mursla Bio

Mursla Bio

Private
CambridgeHealthcare & Life Scienceshttps://mursla.com

Last Round

Convertible Debt

Sep 1, 2020

Total Funding Raised

$602,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mursla Bio is a biotechnology company developing a non-invasive diagnostic platform for the early detection of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share, Government Contracts

AI Layer

Application

Keywords

liquid biopsyorgan-specific EVsextracellular vesiclesEVsearly cancer detectionliver cancer surveillanceAI precision medicinebiomarker discoverymulti-omicscompanion diagnosticsCDxlaboratory developed testLDTexosome analysispatient stratificationMASH diagnosticsdynamic biopsy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mursla Bio Comparables

Compare Mursla Bio with similar companies based on industry and business-model similarity.

Mursla Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Helio Genomics
84%
Mercy BioAnalytics
83%
Glycotest, Inc.
82%

Mursla Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 1, 2020
GrantSep 1, 2020

Key People

Founding team and executive leadership

Pierre Arsène

Founder & CEO

Founding Team

Mursla Bio Investors

Notable investors and investment history

Mursla Bio investors
InvestorRounds
Future FundConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 99% MoM.

  • Mar 26, 2026

    Joined the ABHI US Accelerator program to support US market entry.

Mursla Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mursla Bio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCambridge
Employee Range18
Year Founded2017
Last FundingSep 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?